These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 22069233)

  • 1. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
    Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
    J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
    J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
    Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
    Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
    J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo and experimental internal radionuclide dosimetry in RANDO head phantom.
    Ghahraman Asl R; Nasseri S; Parach AA; Zakavi SR; Momennezhad M; Davenport D
    Australas Phys Eng Sci Med; 2015 Sep; 38(3):465-72. PubMed ID: 26232251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry.
    Yoriyaz H; Stabin MG; dos Santos A
    J Nucl Med; 2001 Apr; 42(4):662-9. PubMed ID: 11337557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
    Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
    Jarry G; Verhaegen F
    Phys Med Biol; 2007 Apr; 52(8):2277-99. PubMed ID: 17404469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Application of Tissue-Specific Dose Kernels Instead of Water Dose Kernels in Internal Dosimetry: A Monte Carlo Study.
    Khazaee Moghadam M; Kamali Asl A; Geramifar P; Zaidi H
    Cancer Biother Radiopharm; 2016 Dec; 31(10):367-379. PubMed ID: 27996311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the need to revise the arm structure in stylized anthropomorphic phantoms in lateral photon irradiation geometry.
    Lee C; Lee C; Lee JK
    Phys Med Biol; 2006 Nov; 51(21):N393-402. PubMed ID: 17047258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy.
    Giap HB; Macey DJ; Podoloff DA
    J Nucl Med; 1995 Oct; 36(10):1885-94. PubMed ID: 7562060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo calculations of absorbed doses in tumours using a modified MOBY mouse phantom for pre-clinical dosimetry studies.
    Larsson E; Ljungberg M; Strand SE; Jönsson BA
    Acta Oncol; 2011 Aug; 50(6):973-80. PubMed ID: 21767199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.
    Bolch WE; Bouchet LG; Robertson JS; Wessels BW; Siegel JA; Howell RW; Erdi AK; Aydogan B; Costes S; Watson EE; Brill AB; Charkes ND; Fisher DR; Hays MT; Thomas SR
    J Nucl Med; 1999 Jan; 40(1):11S-36S. PubMed ID: 9935083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.